SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-16-162170
Filing Date
2016-12-15
Accepted
2016-12-15 06:07:13
Documents
4
Period of Report
2016-12-15

Document Format Files

Seq Description Document Type Size
1 6-K a16-23188_16k.htm 6-K 22657
2 EX-1.1 a16-23188_1ex1d1.htm EX-1.1 266809
3 EX-99.1 a16-23188_1ex99d1.htm EX-99.1 16110
4 EX-99.2 a16-23188_1ex99d2.htm EX-99.2 10925
  Complete submission text file 0001104659-16-162170.txt   317462
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37558 | Film No.: 162052286
SIC: 2834 Pharmaceutical Preparations